论文部分内容阅读
自《中华人民共和国药品管理法》及其相关法律法规颁布实施以来,我国规范运行的药品经营秩序已经基本形成。但是,作为《药品管理法》重点调整的对象之一的非法渠道收售药品行为仍然存在。非法收售药品行为是药品监管部门工作的一大难点,因其情况复杂、涉及人群、利益关系多、难以监控、惩罚困难等情况,监管方法值得探讨。本文从非法收售药品发生的各个环节出发,探讨了其特点、监管现状、难点,并针
Since the promulgation and implementation of the “Drug Administration Law of the People’s Republic of China” and its relevant laws and regulations, the order for the operation of pharmaceuticals in our country has basically taken shape. However, the illegal channel collection and sale of drugs as one of the key revisions of the Drug Administration Law still exist. The illegal collection and sale of pharmaceuticals is a major difficulty in the work of pharmaceutical regulatory authorities. Due to its complex situation, involving people, many kinds of interests, difficulty in monitoring and punishment, supervision methods are worth discussing. This article starts from all aspects of the illegal collection and sale of drugs, discusses its characteristics, regulatory status quo, difficulties, and needles